The risk of SARS-CoV-2 infection and disease severity in a cohort of severe asthmatics treated with biologics
In a recent study published in The Journal of Allergy and Clinical Immunology: In Practiceresearchers assessed the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in asthma patients taking biologics. Study: SARS-Cov-2 infection in severe asthma patients treated with biologics. Image Credit: Prostock studio/Shutterstock background The coronavirus disease 2019 (COVID-19) pandemic remains a …